Litcius/Paper detail

Addictovigilance contribution during COVID-19 epidemic and lockdown in France

Maryse Lapeyre‐Mestre, Alexandra Boucher, Amélie Daveluy, Valérie Gibaja, Émilie Jouanjus, Michel Mallaret, Hélène Peyrière, Joëlle Micallef, Émilie Bouquet, Leïla Chaouachi, Cécile Chevallier, Sylvie Deheul, Céline Eiden, Nathalie Fouilhé, Chistine Fournier-Choma, Élisabeth Frauger, Marylène Guerlais, Reynald Le Boisselier, Ghada Miremont, Anne Roussin, Juliana Tournebize

2020Therapies72 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyMedicineOutbreakInternal medicineInfectious disease (medical specialty)DiseaseOpioid Use Disorder TreatmentPharmacovigilance and Adverse Drug ReactionsHealthcare Decision-Making and Restraints
Addictovigilance contribution during COVID-19 epidemic and lockdown in France | Litcius